Devendra V. Billimoria - Aug 9, 2023 Form 4 Insider Report for LIMEADE, INC (NONE)

Role
Director
Signature
/s/ Paul Crick, Attorney-in-Fact
Stock symbol
NONE
Transactions as of
Aug 9, 2023
Transactions value $
$0
Form type
4
Date filed
8/9/2023, 04:37 PM
Previous filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NONE Common Stock Disposed to Issuer -476K -100% 0 Aug 9, 2023 By Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Devendra V. Billimoria is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On August 9, 2023 (the "Closing Date"), WebMD Health Corp, a Delaware corporation ("Buyer"), acquired the Company pursuant to a certain Agreement and Plan of Merger entered into by and among the Company, Buyer and Lotus Merger Sub, Inc. a Washington corporation and wholly owned subsidiary of Buyer ("Merger Sub"), dated as of June 8, 2023 (the "Merger Agreement"). In accordance with the Merger Agreement, the Company merged with and into Merger Sub, with the Company surviving such merger as a wholly owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Company's common stock (other than certain excluded shares) automatically converted into the right to receive USD$0.284 in cash.

Remarks:

By virtue of the Merger Agreement, the reporting person has ceased being a Section 16 officer of the Company.